Saikosaponin D 5 mg | 99.09%
TargetMol
Saikosaponin D is a novel SERCA inhibitor by inhibiting NF-κB and STAT3 signaling to protect against acetaminophen-induced hepatotoxicity.
More Information Supplier PageSaikosaponin D
Search Results
Saikosaponin D 10 mg | 99.09%
TargetMol
Saikosaponin D is a novel SERCA inhibitor by inhibiting NF-κB and STAT3 signaling to protect against acetaminophen-induced hepatotoxicity.
More Information Supplier PageSaikosaponin D
Bay 59-3074 5 mg | 98.00%
TargetMol
Bay 59-3074 is a CB1/CB2 receptor partial agonist (Ki: 48.3/45.5 nM). In rat models of chronic neuropathic and inflammatory pain, it displays anti-hyperalgesic and antiallodynic properties.
More Information Supplier PageBay 59-3074
Bay 59-3074 50 mg | 98.00%
TargetMol
Bay 59-3074 is a CB1/CB2 receptor partial agonist (Ki: 48.3/45.5 nM). In rat models of chronic neuropathic and inflammatory pain, it displays anti-hyperalgesic and antiallodynic properties.
More Information Supplier PageBay 59-3074
Bay 59-3074 25 mg | 98.00%
TargetMol
Bay 59-3074 is a CB1/CB2 receptor partial agonist (Ki: 48.3/45.5 nM). In rat models of chronic neuropathic and inflammatory pain, it displays anti-hyperalgesic and antiallodynic properties.
More Information Supplier PageBay 59-3074
ICA-069673 100 mg | 99.66%
TargetMol
ICA-069673 is an activator of KCNQ2/Q3 potassium channel (IC50: 0.69 μM).
More Information Supplier PageICA-069673
ICA-069673 10 mg | 99.66%
TargetMol
ICA-069673 is an activator of KCNQ2/Q3 potassium channel (IC50: 0.69 μM).
More Information Supplier PageICA-069673
TOFA 50 mg | 99.71%
TargetMol
TOFA
TOFA 25 mg | 99.71%
TargetMol
TOFA
TOFA 10 mg | 99.71%
TargetMol
TOFA